Results 121 to 130 of about 9,542 (213)

Synthesis of galacto-oligosaccharides with ß-galactosidases

Galacto-oligosaccharides (GOS) are generally enzymatically synthesized with β-galactosidases. GOS are of interest because of their prebiotic effects on human health. They are mainly applied in infant nutrition, because of their resemblance to human milk oligosaccharides, but they are also applied in e.g. dairy products and beverages.
openaire   +1 more source

Safety of the extension of use of galacto-oligosaccharides as a novel food pursuant to Regulation (EU) 2015/2283. [PDF]

EFSA J
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, De Henauw S, Jos Á, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Siani A, Thies F, Aguilera-Gómez M, Frenzel T, McArdle HJ, Moldeus P, Neuhäuser-Berthold M, Schlatter JR, van Loveren H, Turla E, Azzollini D, Hirsch-Ernst KI.   +24 more
europepmc   +1 more source

Early-life galacto-oligosaccharides supplementation alleviates the small intestinal oxidative stress and dysfunction of lipopolysaccharide-challenged suckling piglets. [PDF]

J Anim Sci Biotechnol, 2022
Tian S, Wang J, Gao R, Wang J, Zhu W.
europepmc   +1 more source

One-Pot Enzymatic Bioconversion of Native Whey for the Simultaneous Production of Galacto-Oligosaccharides and Antioxidant Peptides. [PDF]

Foods
Córdova-Suárez A, Cavieres A, Guerrero C, Valencia P, Carrasco V, Vergara M, Catalán S, Arancibia A, Altamirano C, López J, Astudillo-Castro C, Valenzuela N.   +11 more
europepmc   +1 more source

Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses. [PDF]

Metabolites
Harthoorn LF, Heyse J, Baudot A, van Hengel IAJ, Van den Abbeele P.   +4 more
europepmc   +1 more source

Bifidobacterial β-Galactosidase-Mediated Production of Galacto-Oligosaccharides: Structural and Preliminary Functional Assessments. [PDF]

Front Microbiol, 2021
Ambrogi V, Bottacini F, Mac Sharry J, van Breen J, O'Keeffe E, Walsh D, Schoemaker B, Cao L, Kuipers B, Lindner C, Jimeno ML, Doyagüez EG, Hernandez-Hernandez O, Moreno FJ, Schoterman M, van Sinderen D.   +15 more
europepmc   +1 more source

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to Bimuno® GOS and reducing gastro-intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006 [PDF]

, 2011
Bouhnik, Bouhnik, Depeint, Drakoularakou, Goulas, Irvine, Piirainen, Searle, Searle, Shadid, Silk, Teuri, Tzortzis, Tzortzis, Vulevic   +14 more
core   +1 more source

Protective activity of galacto-oligosaccharides against intestinal damage and inflammation induced by enterotoxigenic <i>Escherichia coli</i> F4⁺ and evaluation of prebiotic potential. [PDF]

Front Vet Sci
Guantario B, Tanghe S, Finamore A, Devriendt B, Devirgiliis C, Verstringe S, Rooyackers E, De Vos M, Vande Ginste J, Roselli M.   +9 more
europepmc   +1 more source

Galacto-oligosaccharides alleviate lung inflammation by inhibiting NLRP3 inflammasome activation in vivo and in vitro. [PDF]

J Adv Res, 2022
Cai Y, Gilbert MS, Gerrits WJJ, Folkerts G, Braber S.   +4 more
europepmc   +1 more source

Spatiotemporal dynamics of mucosa-associated <i>Lactobacillus</i> along the small intestine and its response to 2'-fucosyllactose and galacto-oligosaccharides in piglets. [PDF]

Anim Nutr
Fan W, Mu C, Li X, Zhang Y, Yu K, Su Y, Zhu W.   +6 more
europepmc   +1 more source